Betty Ford Lecture Sharon Walsh - AMERSA

More documents

Recommendations

Info

Treatment Admissions InvolvingOpioid Analgesics 1 1992-2006140#120#100#OxyContin® introduced80#60#40#20#0#1992# 1994# 1996# 1998# 2000# 2002# 2004# 2006#Ref: Deborah Trunzo, SAMHSAFDA Advisory Committee 5-5-081Includes admissions where primary, secondary, or tertiarysubstance was reported as Other opiates/synthetics. Excludesadmissions for non-prescription use of methadone. 22
Sustained Release?23
Page 1 and 2: Prescription Opioid Abuse: Translat
Page 3 and 4: OutlineEpidemiology of prescription
Page 5 and 6: Number of New Nonmedical Users of P
Page 7 and 8: Opioid AnalgesicPrescriptions in th
Page 9 and 10: Broward Palm Beach New Times, Volum
Page 11: Abuse Potential vs. Abuse Liability
Page 14 and 15: General Methods Enroll as inpatient
Page 16 and 17: RADARS System Opioid Abuse Trends,P
Page 18 and 19: “How HIGH Are You Right Now?”Or
Page 20 and 21: “How Much Do You LIKE the Drug?In
Page 24 and 25: “How Much Do You Like the Drug?
Page 26 and 27: Oxycodone Plasma ConcentrationsConc
Page 28 and 29: Oral Opioid Self-Administration:Pro
Page 30 and 31: Development of Abuse-Deterrent orAb
Page 32 and 33: Buprenorphine Sublingual buprenorph
Page 34 and 35: Buprenorphine Implementation Benefi
Page 36 and 37: Broward Palm Beach New Times, Volum
Page 38 and 39: RADARS System Opioid Abuse Trends,P
Page 40 and 41: How Do Prescribing Practices Increa
Page 42 and 43: Definitions Diversion: an unauthori
Page 44 and 45: Methods - The Curriculum Gather all
Page 46 and 47: Results CME attendees:Boardcertific
Page 48 and 49: Buprenorphine has an average half-l
Page 50 and 51: What % of your patients are in opio
Page 52 and 53: 100Average Daily Maintenance Dose#B
Page 54 and 55: Confessions of X-Licensed Doctors H
Page 56 and 57: Conclusions Prescription opioid abu

Betty Ford Lecture Sharon Walsh - AMERSA

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?